(Total Views: 551)
Posted On: 09/12/2021 5:03:48 PM
Post# of 145873
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
São Paulo (site of a large proportion of Leronlimab trials) is among the most vaccinated metropolitan areas in Brazil.
This demonstrates a significant effort by São Paulo city and state to protect its citizens.
https://riotimesonline.com/brazil-news/sao-pa...irst-dose/
However, first dose is only 30.7% effective against Delta.
https://www.cidrap.umn.edu/news-perspective/2...inst-delta
Significant need remains for effective therapeutics, in Brazil as elsewhere. Opportunity for leronlimab to demonstrate efficacy remains mostly undiminished.
Quote:
City of São Paulo has vaccinated 96.1% of adult population with first dose
This demonstrates a significant effort by São Paulo city and state to protect its citizens.
https://riotimesonline.com/brazil-news/sao-pa...irst-dose/
However, first dose is only 30.7% effective against Delta.
https://www.cidrap.umn.edu/news-perspective/2...inst-delta
Significant need remains for effective therapeutics, in Brazil as elsewhere. Opportunity for leronlimab to demonstrate efficacy remains mostly undiminished.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)